Higher serum IFN-α levels were positively associated with increased disease activity and autoantibodies in RA patients, while neither IFN-α nor IFN-γ correlated with cardiovascular comorbidities.
Cross-Sectional (n=216)
Are serum levels of IFN-α and IFN-γ associated with disease activity and cardiovascular comorbidities in patients with rheumatoid arthritis?
In patients with rheumatoid arthritis, serum IFN-α levels correlate with disease activity, but neither IFN-α nor IFN-γ are associated with surrogate markers of cardiovascular comorbidity.
Abstract Objective Interferons (IFNs) are implicated in the pathogenesis of rheumatoid arthritis (RA). However, the relationship between serum levels of IFN-α and IFN-γ and the clinical manifestations of RA, particularly regarding cardiovascular comorbidity, remains poorly established. In this study, we aimed to investigate the associations between serum concentrations of IFN-α and IFN-γ and the spectrum of disease manifestations in RA, with special attention to cardiovascular involvement. Methods A total of 216 RA patients were recruited. They underwent comprehensive evaluations, including disease-related characteristics and disease activity indices. Moreover, complete lipid profile, insulin resistance indices, metabolic syndrome criteria, and carotid ultrasound for carotid stiffness, intima-media thickness and carotid plaque detection were assessed. IFN-α and IFN-γ serum levels were measured using Simoa (Single Molecule Array) technique. A multivariable linear regression analysis was performed to examine the associations between the disease characteristics and IFN-α and IFN-γ. Results Serum levels of IFN-α and IFN-γ were significantly correlated with each other and were also associated with circulating levels of interleukin 2, 6, and 8. After multivariable adjustment, higher serum IFN-α levels were positively associated with rheumatoid factor and anti-citrullinated protein antibodies positivity, as well as with increased disease activity scores. In contrast, IFN-γ levels showed no significant associations with most clinical manifestations of RA. Furthermore, neither IFN-α nor IFN-γ levels were related to cardiovascular comorbidities, including lipid profiles, insulin resistance indices, or carotid ultrasound findings. Conclusion Serum levels of IFN-α, but not IFN-γ, are associated with disease activity in patients with RA. However, neither IFN is correlated with the cardiovascular comorbidities commonly observed in this population.
Gómez-Bernal et al. (2026) conducted a cross-sectional in rheumatoid arthritis (n=216). Serum levels of IFN-α and IFN-γ was evaluated on Associations between serum concentrations of IFN-α and IFN-γ and disease manifestations, including cardiovascular involvement. Higher serum IFN-α levels were positively associated with increased disease activity and autoantibodies in RA patients, while neither IFN-α nor IFN-γ correlated with cardiovascular comorbidities.